Cargando…
Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis
BACKGROUND: It remains controversial whether the platelet to lymphocyte ratio (PLR) serves as a potential indicator for the efficacy of immunotherapy in advanced lung cancer. This meta-analysis aimed to address this concern. METHODS: Up to March 2022, we searched PubMed, Embase, Web of Science and t...
Autores principales: | Zhou, Ke, Cao, Jie, Lin, Huahang, Liang, Linchuan, Shen, Zhongzhong, Wang, Lei, Peng, Zhiyu, Mei, Jiandong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437586/ https://www.ncbi.nlm.nih.gov/pubmed/36059629 http://dx.doi.org/10.3389/fonc.2022.962173 |
Ejemplares similares
-
Surgery and chemotherapy cannot improve the survival of patients with early-stage mucosa-associated lymphoid tissue derived primary pulmonary lymphoma
por: Lin, Huahang, et al.
Publicado: (2022) -
Pretreatment platelet-to-lymphocyte ratio (PLR) as a prognosticating indicator for gastric cancer patients receiving immunotherapy
por: Gou, Miaomiao, et al.
Publicado: (2022) -
Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis
por: Zhou, Ke, et al.
Publicado: (2022) -
Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis
por: Qi, Xue, et al.
Publicado: (2023) -
Prognostic Value of Platelet to Lymphocyte Ratio (PLR) and Neutrophil to Lymphocyte Ratio (NLR) in Patients with Pulmonary Hypertension
por: Shahmoradi, Zahra, et al.
Publicado: (2022)